98 related articles for article (PubMed ID: 7131266)
1. High-performance liquid chromatographic analysis of digitoxin formulations.
Desta B; McErlane KM
J Pharm Sci; 1982 Sep; 71(9):1018-20. PubMed ID: 7131266
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic analysis of digoxin formulations.
Desta B; McErlane KM
J Pharm Sci; 1982 Jul; 71(7):777-80. PubMed ID: 7120061
[TBL] [Abstract][Full Text] [Related]
3. Determination of cardiac glycosides in digitoxin tablets and deslanoside injections by micro-HPLC.
Fujii Y; Ikeda Y; Yamazaki M
J Chromatogr Sci; 1990 Jun; 28(6):288-91. PubMed ID: 2246351
[TBL] [Abstract][Full Text] [Related]
4. Separation of digoxin, digitoxin and their potential metabolites, impurities or degradation products by high-performance liquid chromatography.
Desta B; Kwong E; McErlane KM
J Chromatogr; 1982 May; 240(1):137-43. PubMed ID: 7096512
[TBL] [Abstract][Full Text] [Related]
5. Detection of digoxin, digitoxin, their cardioactive metabolites and derivatives by high-performance liquid chromatography and high-performance liquid chromatography-radioimmunoassay.
Plum J; Daldrup T
J Chromatogr; 1986 Apr; 377():221-31. PubMed ID: 3711211
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.
Garnick RL; Burt GF; Long DA; Bastian JW; Aldred JP
J Pharm Sci; 1984 Jan; 73(1):75-7. PubMed ID: 6694088
[TBL] [Abstract][Full Text] [Related]
7. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity.
Rapaka RS; Knight PW; Prasad VK
J Pharm Sci; 1981 Feb; 70(2):131-4. PubMed ID: 7205213
[TBL] [Abstract][Full Text] [Related]
8. Simple high-performance liquid chromatographic assay for norethindrone--mestranol in combination tablets.
Sundaresan GM; Goehl TJ; Prasad VK
J Pharm Sci; 1981 Jun; 70(6):702-4. PubMed ID: 7252827
[TBL] [Abstract][Full Text] [Related]
9. Automated fluorometric procedure for unit dose analysis of digitoxin and digoxin in tablet formulations.
Cullen LF; Packmsn DL; Papariello GJ
J Pharm Sci; 1970 May; 59(5):697-9. PubMed ID: 5446430
[No Abstract] [Full Text] [Related]
10. Analysis of oxprenolol in formulations by high-performance liquid chromatography.
El-Yazigi A
J Pharm Sci; 1984 Jun; 73(6):751-4. PubMed ID: 6145788
[TBL] [Abstract][Full Text] [Related]
11. Rapid and specific high-pressure liquid chromatographic assay for folic acid in multivitamin-mineral pharmaceutical preparations.
Tafolla WH; Sarapu AC; Dukes GR
J Pharm Sci; 1981 Nov; 70(11):1273-6. PubMed ID: 7299676
[TBL] [Abstract][Full Text] [Related]
12. A rapid HPLC method for determination of zolpidem and its degradation product in tablets using a monolithic column.
Rezaee Zavareh E; Kiani A; Sheikholeslam Z; Shafaati A; Tabatabai SA
J Chromatogr Sci; 2015; 53(5):807-10. PubMed ID: 25754693
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic determination of cyproheptadine hydrochloride in tablet formulations.
Burrows GW; Alliger CL
J Pharm Sci; 1983 Oct; 72(10):1212-3. PubMed ID: 6644574
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic determination of perphenazine and amitriptyline hydrochloride in two-component tablet formulations.
Butterfield AG; Sears RW
J Pharm Sci; 1977 Aug; 66(8):1117-9. PubMed ID: 894497
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic analysis of nadolol and bendroflumethiazide combination tablet formulations.
Perlman S; Szyper M; Kirschbaum JJ
J Pharm Sci; 1984 Feb; 73(2):259-61. PubMed ID: 6707897
[TBL] [Abstract][Full Text] [Related]
16. Rapid high pressure liquid chromatographic determination of amitriptyline hydrochloride in tablets and injectables: collaborative study.
Walker ST
J Assoc Off Anal Chem; 1983 Sep; 66(5):1196-202. PubMed ID: 6630133
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous high-performance liquid chromatographic determination of chlordiazepoxide and amitriptyline hydrochloride in two-component tablet formulations.
Burke D; Sokoloff H
J Pharm Sci; 1980 Feb; 69(2):138-40. PubMed ID: 7359310
[TBL] [Abstract][Full Text] [Related]
18. A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations.
Kazemifard AG; Javadzadeh N; Gholami K
Acta Pol Pharm; 2008; 65(2):179-86. PubMed ID: 18666423
[TBL] [Abstract][Full Text] [Related]
19. Determination of potential content of vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) in gelatin-coated beadlets, oil-based mixtures, and multivitamin tablet and capsule formulations.
Walker GA; Carpenter BE; Tuescher DL
J Pharm Sci; 1980 Jul; 69(7):846-9. PubMed ID: 6248625
[TBL] [Abstract][Full Text] [Related]
20. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
Richheimer SL; Amer TM
J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
